tiprankstipranks
Trending News
More News >
Luxbright AB (SE:LXB)
:LXB
Advertisement

Luxbright AB (LXB) AI Stock Analysis

Compare
0 Followers

Top Page

SE:LXB

Luxbright AB

(Frankfurt:LXB)

Select Model
Select Model
Select Model
Neutral 50 (OpenAI - 4o)
Rating:50Neutral
Price Target:
kr0.50
▼(-30.56% Downside)
Luxbright AB's overall stock score is primarily impacted by its challenging financial performance, characterized by ongoing losses and negative cash flows. While technical analysis shows some short-term bullish momentum, the company's negative valuation metrics due to unprofitability weigh heavily on the score. The absence of earnings call data and corporate events means these factors do not influence the score.

Luxbright AB (LXB) vs. iShares MSCI Sweden ETF (EWD)

Luxbright AB Business Overview & Revenue Model

Company DescriptionLuxbright AB (publ), a technology company, develops and commercializes X-ray tubes, generators, and X-ray systems to system suppliers. The company was incorporated in 2012 and is headquartered in Gothenburg, Sweden.
How the Company Makes MoneyLuxbright AB generates revenue through multiple streams, primarily by selling its range of LED lighting products to wholesalers, retailers, and direct consumers. The company also offers tailored lighting design services, which provide added value to commercial clients looking to optimize their lighting solutions for energy savings and aesthetic appeal. Additionally, LXB has established strategic partnerships with construction firms and energy service companies, allowing it to integrate its products into larger projects and benefit from shared revenue opportunities. The company's focus on research and development enables it to stay competitive, introducing innovative products that cater to evolving market demands, further enhancing its revenue potential.

Luxbright AB Financial Statement Overview

Summary
Luxbright AB is in a challenging financial position with ongoing losses, despite revenue growth and a strong equity base. The lack of profitability and negative cash flows suggest high financial risk, which may require strategic adjustments to enhance operational efficiency and financial performance.
Income Statement
25
Negative
Luxbright AB has shown significant revenue growth in the most recent year, but the company remains unprofitable with negative EBIT and net income over the past years. The gross profit margin is high at 98.4% for 2024, but the net profit margin is negative due to high operating expenses. The continuous losses are a significant concern despite revenue growth.
Balance Sheet
40
Negative
The company has a strong equity position with no debt, resulting in a debt-to-equity ratio of zero. However, the return on equity (ROE) remains negative due to continued net losses. The equity ratio is stable, showing a solid foundation, but profitability issues weigh on the overall balance sheet health.
Cash Flow
30
Negative
Luxbright AB's operating cash flow and free cash flow are consistently negative, indicating cash burn. The financing cash flow has been positive, suggesting reliance on external funding. The free cash flow to net income ratio is not favorable, highlighting a need for improved cash generation from operations.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue10.89M9.02M854.70K811.70K729.00K614.29K
Gross Profit-6.02M8.88M-2.80M189.12K1.98M1.57M
EBITDA-15.63M-15.72M-23.87M-20.47M-17.63M-12.18M
Net Income-18.40M-17.72M-25.38M-21.13M-18.10M-12.38M
Balance Sheet
Total Assets50.10M42.66M40.69M31.19M23.99M44.11M
Cash, Cash Equivalents and Short-Term Investments16.32M12.36M14.04M7.60M7.51M29.51M
Total Debt5.11M254.19K206.02K588.34K1.10M1.81M
Total Liabilities13.41M8.46M7.00M3.33M3.36M5.47M
Stockholders Equity36.69M34.20M33.69M27.86M20.63M38.64M
Cash Flow
Free Cash Flow-19.85M-16.52M-20.39M-20.64M-17.14M-13.67M
Operating Cash Flow-19.85M-16.52M-20.39M-20.64M-17.14M-13.67M
Investing Cash Flow-3.76M-3.44M-3.99M-7.15M-4.15M-3.42M
Financing Cash Flow35.59M18.28M30.82M27.88M-708.00K40.26M

Luxbright AB Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.72
Price Trends
50DMA
0.70
Positive
100DMA
0.70
Positive
200DMA
0.74
Negative
Market Momentum
MACD
<0.01
Negative
RSI
53.85
Neutral
STOCH
43.96
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:LXB, the sentiment is Positive. The current price of 0.72 is above the 20-day moving average (MA) of 0.70, above the 50-day MA of 0.70, and below the 200-day MA of 0.74, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 53.85 is Neutral, neither overbought nor oversold. The STOCH value of 43.96 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SE:LXB.

Luxbright AB Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
58
Neutral
€196.35M-78.89%57.14%81.07%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
50
Neutral
kr93.97M-60.20%163.12%30.50%
46
Neutral
kr136.68M-210.52%34.78%26.34%
39
Underperform
€73.36M-19.36%-61.38%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SE:LXB
Luxbright AB
0.72
-0.29
-28.51%
SE:SCIB
SciBase Holding AB
0.33
-0.18
-34.65%
SE:CLS.B
Clinical Laserthermia Systems AB Class B
7.65
2.79
57.44%
SE:SPEC
SpectraCure AB
0.18
-0.60
-76.84%
SE:SDOS
ScandiDos AB
1.12
-0.58
-34.12%
SE:ARCOMA
Arcoma AB
9.12
-5.68
-38.38%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 11, 2025